| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009844 Inhibitors of p38 |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009730 Sleep disorders; side effect reduction |
| 01/13/2005 | US20050009704 Substituted aryl ketones |
| 01/13/2005 | US20050006625 group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption |
| 01/13/2005 | DE10328173A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | DE10328171A1 Triazolopyrimidine Triazolopyrimidines |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530389A1 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 01/12/2005 | EP1494991A1 Analogous compounds of strobilurines and their use as acaricides and insecticides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494645A2 Method of treating mucus hypersecretion |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1562972A Medicinal compound for curing disease of gastrointestinal tract, preparation method and relevant medication |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/12/2005 | CN1184207C Process for producing insecticide intermediate |
| 01/12/2005 | CN1184205C Method for synthesizing pasiniazide |
| 01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 01/11/2005 | US6841693 Transition metal compound, olefin polymerization catalyst, and method of polymerizing olefin |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841676 Stereospecific catalysts for polymerization of addition polymerizable monomers |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 01/11/2005 | US6841502 For catalytic polymerization of ethylene/olefin copolymers |
| 01/11/2005 | US6841304 Dissolves other salts, in particular metallic salts, such as lithium salts, to give highly conductive solutions |
| 01/11/2005 | CA2320217C N-(phenylsulfonyl) picolinamide derivatives, process for producing the same, and herbicide |
| 01/06/2005 | WO2005000855A1 Process for the preparation of atropisomeric analogues of 4-aminopyridine |
| 01/06/2005 | WO2005000851A1 Pyrazolopyrimidines |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000818A1 5-substituted-4-`(substituted phenyl)!amino!-2-pyridone deviatives for use as mek inhibitors |
| 01/06/2005 | WO2005000817A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | WO2005000816A1 Process for the production of pyridine and picolines |
| 01/06/2005 | WO2005000804A2 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000798A1 Heterocyclic methyl sulfone derivative |
| 01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
| 01/06/2005 | WO2005000781A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | WO2005000778A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | WO2005000232A2 Six membered amino-amide derivatives as angiogenesis inhibitors |
| 01/06/2005 | WO2005000109A2 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 01/06/2005 | WO2004071388A3 Medicinal compounds |
| 01/06/2005 | WO2003032912A9 Treatment of cns disorders using cns target modulators |
| 01/06/2005 | US20050004232 Acyl sulfonamides as inhibitors of HIV integrase |
| 01/06/2005 | US20050004212 Antitumor/cancer activity; topoisomerase I inhibitors |
| 01/06/2005 | US20050004211 Inhibiting topoisomerase I; blocking S or G2/M phase of tumor and/or cancer cells |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004205 Such as 1-[N alpha -(1'-Acetoxyethoxycarbonyl)-N omega -(pyrazinyl-2-carbonyl)-L-ornithinyl]-pyrrolidine-2-carbonitrile; impaired glucose tolerance, type II diabetes, hypoglycaemia |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004182 2-Amino-pyridine derivatives useful for the treatment of diseases |
| 01/06/2005 | US20050004168 New substituted pyridine or piperidine compounds |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004151 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 01/06/2005 | US20050003075 Volatile copper(II) complexes for deposition of copper films by atomic layer deposition |
| 01/06/2005 | US20050003031 Anti-cancer compounds |
| 01/06/2005 | US20050002485 Method and apparatus of producing organic compound |
| 01/06/2005 | US20050000034 For human hair, wool, leather, cotton, nylon |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | CA2530378A1 Pyrazolopyrimidines |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | CA2528619A1 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | CA2526988A1 Substituted indoles and a process for preparing substituted indoles |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493733A2 Fungicidal heterocyclic aromatic amides, their compositions and methods of use |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492770A1 Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines |
| 01/05/2005 | EP1492769A2 Novel process |
| 01/05/2005 | EP1492768A1 Phenethylacrylamide, methods for the production thereof and agents containing the same |
| 01/05/2005 | EP1492763A1 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |